Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Operating Margin (2011 - 2026)

Innoviva's (INVA) quarterly Operating Margin came in at 38.94% in Q1 2026, down 781.0% YoY from 5.72% in Q1 2025, and up 103.06% on a QoQ basis from 1274.01% in Q4 2025.

Analysis

Innoviva (INVA) Operating Margin (2011 - 2026) Analysis & Trends

Innoviva (INVA) has 16 years of Operating Margin data on file, last reported at 38.94% in Q1 2026.

  • Quarterly Operating Margin fell 781.0% year-over-year to 38.94% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 39.88% (down 595.0% YoY) and the FY2025 annual result came in at 39.81%, down 671.0% from the prior year.
  • Operating Margin grew to 38.94% in Q1 2026, from 1274.01% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 58.45% in Q3 2023 to a low of 1274.01% in Q4 2025.
  • A 5-year average of 434.34% and a median of 430.5% in 2023 frame the typical range for Operating Margin.
  • Annual changes were most pronounced in 2022 — Operating Margin tumbled 411120 bps — and 2024, when it surged 116203 bps.
  • Tracing INVA's Operating Margin over 5 years: stood at 982.68% in 2022, then surged by 56 bps to 430.5% in 2023, then slumped by 98 bps to 853.36% in 2024, then sank by 49 bps to 1274.01% in 2025, then soared by 103 bps to 38.94% in 2026.
  • The last three Operating Margin figures came in at 38.94% (Q1 2026), 1274.01% (Q4 2025), and 42.05% (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 30.15%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 32.54%
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -562.07%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 19.06%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 17.93%
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.75%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.36%
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn 42.52%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.52%
Mar 31, 2026 38.94%
Dec 31, 2025 -1,274.01%
Sep 30, 2025 42.05%
Jun 30, 2025 48.61%
Mar 31, 2025 46.74%
Dec 31, 2024 -853.36%
Sep 30, 2024 46.36%
Jun 30, 2024 54.74%
Mar 31, 2024 33.30%
Dec 31, 2023 -430.50%
Sep 30, 2023 46.74%
Jun 30, 2023 -38.65%
Mar 31, 2023 -28.38%
Dec 31, 2022 -982.68%
Sep 30, 2022 27.00%
Jun 30, 2022 76.28%
Mar 31, 2022 86.31%
Dec 31, 2021 -611.53%
Sep 30, 2021 95.21%